Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 42 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 821

Topic: Biology, Genetics & Bone Healing

Recombinant human bone morphogenetic proteins (rhBMPs) are used clinically to enhance bone healing. BMPs belong to the TGF-beta superfamily. They initiate intracellular signaling primarily by binding to transmembrane receptors that activate which of the following downstream molecules?

. JAK/STAT pathway
. cAMP/PKA pathway
. Smad proteins
. Wnt/beta-catenin
. MAP kinases

Correct Answer & Explanation

. Smad proteins

Explanation

Bone morphogenetic proteins (BMPs) bind to serine/threonine kinase receptors (Type I and Type II) on the cell surface. This binding phosphorylates and activates receptor-regulated Smads (R-Smads, specifically Smad 1, 5, and 8), which then complex with Co-Smad (Smad 4) and translocate to the nucleus to regulate the transcription of osteogenic genes.

Question 822

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs) play a critical role in osteoinduction and are members of the transforming growth factor-beta (TGF-beta) superfamily. Following the binding of a BMP ligand to its transmembrane serine/threonine kinase receptor, which intracellular signaling molecules are directly phosphorylated to translocate to the nucleus and initiate transcription of osteogenic genes?

. MAP kinases (ERK, JNK)
. JAK and STAT proteins
. Smad 1, 5, and 8
. Beta-catenin and TCF/LEF
. NF-kappa B

Correct Answer & Explanation

. Smad 1, 5, and 8

Explanation

BMP signaling operates primarily through the canonical Smad pathway. When BMP binds to its type I and type II serine/threonine kinase receptors, it induces phosphorylation of the receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These phosphorylated R-Smads then form a complex with the common-partner Smad (co-Smad, Smad 4) and translocate to the nucleus to regulate the transcription of target genes necessary for osteoblast differentiation.

Question 823

Topic: Biology, Genetics & Bone Healing

During fracture healing via endochondral ossification, undifferentiated mesenchymal stem cells are directed to differentiate along various lineages. Which of the following transcription factors is considered the essential "master regulator" for the differentiation of mesenchymal stem cells into osteoblasts?

. SOX9
. Runx2 (Cbfa1)
. PPAR-gamma
. HIF-1 alpha
. MyoD

Correct Answer & Explanation

. Runx2 (Cbfa1)

Explanation

Runx2 (also known as Cbfa1) is the core transcription factor required for osteoblast differentiation and bone formation. A deficiency in Runx2 leads to cleidocranial dysplasia. SOX9 directs chondrogenic differentiation, PPAR-gamma directs adipogenesis, and MyoD directs myogenesis.

Question 824

Topic: Biology, Genetics & Bone Healing

A 28-year-old female undergoes curettage for a giant cell tumor (GCT) of the distal femur. The histology demonstrates multinucleated giant cells within a stroma of mononuclear cells. The neoplastic mononuclear cells express a specific ligand that promotes the recruitment and formation of the reactive osteoclast-like giant cells. What is this ligand?

. Osteoprotegerin (OPG)
. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL)
. Bone Morphogenetic Protein-2 (BMP-2)
. Fibroblast Growth Factor-23 (FGF-23)
. Transforming Growth Factor-beta (TGF-beta)

Correct Answer & Explanation

. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL)

Explanation

In Giant Cell Tumor of bone, the neoplastic cells are actually the spindled mononuclear stromal cells. These cells highly express RANKL, which binds to RANK on normal macrophages, driving them to fuse and differentiate into the massive, bone-destroying osteoclast-like giant cells. Denosumab, a monoclonal antibody against RANKL, is utilized therapeutically for unresectable GCT.

Question 825

Topic: Biology, Genetics & Bone Healing

The osteoinductive properties of bone grafts are heavily mediated by Bone Morphogenetic Proteins (BMPs). Which of the following BMPs is an FDA-approved recombinant product specifically indicated for the treatment of acute open tibial shaft fractures treated with an intramedullary nail?

. BMP-2 (rhBMP-2)
. BMP-3
. BMP-4
. BMP-7 (rhOP-1)
. BMP-9

Correct Answer & Explanation

. BMP-2 (rhBMP-2)

Explanation

Recombinant human BMP-2 (rhBMP-2) is FDA approved for acute open tibial shaft fractures (and anterior lumbar interbody fusions). rhBMP-7 (also known as Osteogenic Protein-1 or OP-1) previously held a Humanitarian Device Exemption for recalcitrant tibial nonunions.

Question 826

Topic: Biology, Genetics & Bone Healing

A 28-year-old female presents with knee pain. Radiographs reveal an eccentric, lytic, epiphyseal-metaphyseal lesion in the proximal tibia extending to the subchondral bone without a sclerotic rim. Biopsy shows multinucleated giant cells in a stroma of mononuclear cells. Which of the following is the primary neoplastic cell in this lesion?

. Multinucleated giant cell
. Osteoblast
. Spindle-shaped stromal cell
. Chondrocyte
. Histiocyte

Correct Answer & Explanation

. Spindle-shaped stromal cell

Explanation

In Giant Cell Tumor of bone (GCT), the true neoplastic cells are the mononuclear spindle-shaped stromal cells which express RANKL. The multinucleated giant cells are reactive osteoclast-like cells expressing RANK, recruited by the neoplastic stromal cells.

Question 827

Topic: Biology, Genetics & Bone Healing
During secondary (indirect) bone healing, the fracture callus undergoes several physiological stages. Which type of collagen is predominately synthesized during the soft callus (chondrogenic) phase?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen

Explanation

During indirect bone healing, the soft callus phase involves endochondral ossification, where chondrocytes produce a cartilaginous matrix rich in Type II collagen. Later, during the hard callus and remodeling phases, osteoblasts replace this matrix with Type I collagen.

Question 828

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs), such as rhBMP-2, are used clinically to stimulate osteoinduction during spinal fusion and fracture nonunion repair. Upon binding to their transmembrane serine/threonine kinase receptors, BMPs initiate intracellular signaling primarily via phosphorylation of which of the following molecules?

. Beta-catenin
. STAT3
. Smad 1/5/8
. Hes1
. ERK1/2

Correct Answer & Explanation

. Smad 1/5/8

Explanation

BMPs signal primarily through the canonical Smad pathway. When BMP binds to its receptor complex, it phosphorylates the receptor-regulated Smads (Smad 1, 5, and 8). These then complex with the common-mediator Smad (Smad 4) and translocate to the nucleus to regulate transcription of osteogenic genes. Beta-catenin is part of the Wnt pathway.

Question 829

Topic: Biology, Genetics & Bone Healing

Denosumab has emerged as an important pharmacological treatment for advanced, recurrent, or unresectable Giant Cell Tumor (GCT) of bone. This monoclonal antibody exerts its therapeutic effect by specifically binding to and inhibiting which of the following targets?

. Receptor Activator of Nuclear factor Kappa B (RANK)
. Receptor Activator of Nuclear factor Kappa B Ligand (RANKL)
. Osteoprotegerin (OPG)
. Macrophage colony-stimulating factor (M-CSF)
. Vascular Endothelial Growth Factor (VEGF)

Correct Answer & Explanation

. Receptor Activator of Nuclear factor Kappa B Ligand (RANKL)

Explanation

Denosumab is a fully human monoclonal antibody that binds to RANKL (Receptor Activator of Nuclear factor Kappa B Ligand). In Giant Cell Tumor of bone, the neoplastic mononuclear stromal cells express high levels of RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclast-like cells) responsible for massive bone destruction. Denosumab inhibits this interaction.

Question 830

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) initiate their intracellular osteoinductive signaling cascade primarily through which of the following mechanisms?

. Activation of G-protein coupled receptors
. Tyrosine kinase receptor phosphorylation
. Binding to serine/threonine kinase receptors and Smad activation
. Inhibition of the Wnt/beta-catenin pathway
. Direct binding to DNA transcription factors

Correct Answer & Explanation

. Binding to serine/threonine kinase receptors and Smad activation

Explanation

BMPs are members of the TGF-beta superfamily. They bind to transmembrane serine/threonine kinase receptors (Types I and II), which leads to the phosphorylation and activation of intracellular Smad proteins (typically Smad 1, 5, and 8). These Smads then form a complex with Smad 4, translocate to the nucleus, and regulate gene transcription for osteoblast differentiation.

Question 831

Topic: Biology, Genetics & Bone Healing
During the normal process of secondary fracture healing, the soft callus phase is crucial for stabilizing the fracture site. Which type of collagen is predominately synthesized and deposited by chondrocytes during this specific phase?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen

Explanation

Secondary fracture healing proceeds through inflammation, soft callus formation, hard callus formation, and remodeling. The soft callus is primarily cartilaginous and is composed mostly of Type II collagen synthesized by chondrocytes. As healing progresses to the hard callus phase (endochondral ossification), chondrocytes hypertrophy and secrete Type X collagen, eventually being replaced by osteoblasts laying down Type I collagen.

Question 832

Topic: Biology, Genetics & Bone Healing

Sclerostin is a key negative regulator of bone formation that has become a therapeutic target for osteoporosis. Which of the following cells is the primary source of sclerostin, and which signaling pathway does it directly inhibit?

. Osteoblasts; Wnt/beta-catenin pathway
. Osteocytes; Wnt/beta-catenin pathway
. Osteoclasts; RANK/RANKL pathway
. Osteocytes; BMP/Smad pathway
. Chondrocytes; Hedgehog pathway

Correct Answer & Explanation

. Osteocytes; Wnt/beta-catenin pathway

Explanation

Sclerostin is a glycoprotein encoded by the SOST gene and is primarily secreted by mature osteocytes. It inhibits bone formation by binding to LRP5/6 receptors on osteoblasts, thereby competitively antagonizing the canonical Wnt/beta-catenin signaling pathway.

Question 833

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with an extensive, locally aggressive Giant Cell Tumor of Bone (GCTB) in the distal femur that is not currently amenable to joint-sparing surgery. She is started on denosumab therapy. Which of the following best describes the cellular mechanism of action of this medication?

. It directly induces apoptosis of the neoplastic mononuclear stromal cells
. It binds to the RANK receptor on osteoclast precursors, inhibiting their activation
. It is a monoclonal antibody that binds directly to RANKL, preventing osteoclastogenesis
. It inhibits the Wnt/beta-catenin pathway, upregulating osteoblastic bone deposition
. It is a tyrosine kinase inhibitor targeting the VEGF receptor to reduce tumor angiogenesis

Correct Answer & Explanation

. It is a monoclonal antibody that binds directly to RANKL, preventing osteoclastogenesis

Explanation

Giant Cell Tumor of Bone consists of neoplastic mononuclear stromal cells that express high levels of Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). This RANKL recruits and activates reactive, multinucleated osteoclast-like giant cells that cause bone destruction. Denosumab is a fully human monoclonal antibody that binds to RANKL, preventing it from binding to the RANK receptor on osteoclasts/giant cells, thus halting their formation and bone resorption.

Question 834

Topic: Biology, Genetics & Bone Healing

During secondary (indirect) fracture healing, the transition from soft callus to hard callus is mediated primarily by which of the following processes?

. Endochondral ossification
. Intramembranous ossification
. Appositional ossification
. Creeping substitution
. Haversian remodeling

Correct Answer & Explanation

. Endochondral ossification

Explanation

Secondary fracture healing involves the formation of a soft cartilaginous callus, which is subsequently mineralized and replaced by bone. This process, where bone replaces a cartilage template, is known as endochondral ossification. Intramembranous ossification (bone formation without a cartilage template) occurs during primary fracture healing and at the periosteal margins.

Question 835

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with pain in her knee. Radiographs reveal an eccentric, lytic lesion in the distal femur that extends to the subchondral bone without a sclerotic margin. Biopsy shows multinucleated giant cells intermixed with mononuclear stromal cells. If surgical curettage is planned, which adjuvant systemic therapy can be used to downstage the tumor or treat unresectable disease?

. Imatinib
. Denosumab
. Methotrexate
. Doxorubicin
. Zoledronic acid

Correct Answer & Explanation

. Denosumab

Explanation

The diagnosis is Giant Cell Tumor (GCT) of bone. The neoplastic mononuclear stromal cells express RANKL, which recruits and activates the multinucleated osteoclast-like giant cells responsible for the aggressive bone resorption. Denosumab, a human monoclonal antibody against RANKL, halts this process, leading to tumor ossification and is highly effective as a neoadjuvant or primary treatment for aggressive or unresectable GCT.

Question 836

Topic: Biology, Genetics & Bone Healing

Calcium phosphate ceramics are frequently used as bone graft substitutes in orthopedic surgery. Which of the following accurately describes their primary biologic property during bone healing?

. They provide both osteoinductive and osteogenic properties
. They act solely as an osteoconductive scaffold
. They contain active bone morphogenetic proteins (BMPs)
. They release live osteoblasts into the defect
. They provide immediate structural cortical strength equal to autograft

Correct Answer & Explanation

. They act solely as an osteoconductive scaffold

Explanation

Calcium phosphate ceramics (along with calcium sulfates and hydroxyapatite) are purely osteoconductive. They provide a three-dimensional scaffold for host bone cells to migrate into and deposit new bone. They do not contain living cells (therefore are not osteogenic) and do not contain proteins like BMPs that stimulate mesenchymal stem cell differentiation (therefore are not osteoinductive).

Question 837

Topic: Biology, Genetics & Bone Healing

Demineralized bone matrix (DBM) is widely used in orthopedic surgery as a bone graft substitute. Which of the following best describes its innate biological properties prior to being mixed with any marrow elements?

. Osteoinductive, osteoconductive, and osteogenic
. Purely osteoconductive with no osteoinductive properties
. Osteoinductive and osteoconductive, but lacks osteogenic cells
. Purely osteoinductive with no osteoconductive properties
. Osteogenic and osteoconductive, but lacks osteoinductivity

Correct Answer & Explanation

. Osteoinductive and osteoconductive, but lacks osteogenic cells

Explanation

Demineralized bone matrix (DBM) provides a collagenous scaffold (osteoconductive) and contains bone morphogenetic proteins (BMPs) exposed by the demineralization process (osteoinductive). However, it contains no living cells, so it is not osteogenic.

Question 838

Topic: Biology, Genetics & Bone Healing

Which of the following Bone Morphogenetic Proteins (BMPs) is FDA-approved for use in acute, open tibial shaft fractures?

. BMP-2
. BMP-3
. BMP-4
. BMP-7
. BMP-9

Correct Answer & Explanation

. BMP-2

Explanation

Recombinant human BMP-2 (rhBMP-2) is FDA-approved for acute, open tibial shaft fractures treated with an intramedullary nail. rhBMP-7 was previously approved under a Humanitarian Device Exemption for recalcitrant nonunions but is no longer commercially available. BMP-3 is an antagonist to osteogenesis.

Question 839

Topic: Biology, Genetics & Bone Healing

Osteoclasts are multinucleated cells responsible for bone resorption. Which of the following signaling molecules directly binds to its receptor on the osteoclast precursor to stimulate its differentiation and activation?

. Osteoprotegerin (OPG)
. Macrophage colony-stimulating factor (M-CSF)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Interleukin-1 (IL-1)
. Transforming growth factor beta (TGF-b)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)

Explanation

RANKL (Receptor activator of nuclear factor kappa-B ligand) is secreted by osteoblasts and binds to the RANK receptor on osteoclast precursors, stimulating their differentiation, activation, and survival. OPG acts as a decoy receptor for RANKL, inhibiting osteoclastogenesis. M-CSF is also required for osteoclast survival but it acts on the c-fms receptor earlier in the lineage.

Question 840

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with knee pain. Radiographs reveal an eccentric, lytic, expansile lesion in the distal femoral epiphysis extending to the articular surface without a sclerotic margin. Biopsy shows multinucleated giant cells uniformly distributed among mononuclear stromal cells. Which of the following targeted medical therapies acts by binding to RANKL and is FDA-approved for unresectable or recurrent cases of this tumor?

. Imatinib
. Denosumab
. Zoledronic acid
. Methotrexate
. Doxorubicin

Correct Answer & Explanation

. Denosumab

Explanation

The diagnosis is a Giant Cell Tumor (GCT) of bone. The mononuclear stromal cells in GCT express RANKL, which recruits and activates the osteoclast-like multinucleated giant cells responsible for the aggressive osteolysis. Denosumab is a monoclonal antibody that binds to RANKL, preventing osteoclast activation, and is highly effective in treating advanced or unresectable GCTs.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page